BIOMAT Database Logo BIOMAT Database Logo

Effect of insulin-like growth factor-I during the early postnatal period in intrauterine growth-restricted rats. 2016

Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

BACKGROUND Insulin-like growth factor-I (IGF-I) is essential for perinatal growth and development; low serum IGF-I has been observed during intrauterine growth restriction (IUGR). We investigated the effects of recombinant human (rh) IGF-I in IUGR rats during the early postnatal period. METHODS Intrauterine growth restriction was induced by bilateral uterine artery ligation in pregnant rats. IUGR pups were divided into two groups injected daily with rhIGF-I (2 mg/kg; IUGR/IGF-I, n = 16) or saline (IUGR/physiologic saline solution (PSS), n = 16) from postnatal day (PND) 7 to 13. Maternal sham-operated pups injected with saline were used as controls (control, n = 16). Serum IGF-I and IGF binding proteins (IGFBP) 3 and 5 were measured on PND25. The expression of Igf-i, IGF-I receptor (Igf-ir), Igfbp3, and 5 mRNA in the liver and brain was measured using real-time polymerase chain reaction on PND25. Immunohistochemical staining of the liver for IGF expression was performed. RESULTS Mean bodyweight on PND3 and PND25 in the IUGR pups (IUGR/IGF-I and IUGR/PSS) was significantly lower than that of the control pups. Serum IGF-I and hepatic Igf-ir mRNA in the IUGR pups were significantly lower than those in the control pups. In the IUGR/IGF-I group, hepatic Igfbp3 mRNA and liver immunohistochemical staining were increased. In the IUGR/PSS and control pups, there were no significant differences between these two groups in serum IGFBP3 and IGFBP5, hepatic Igf-i and Igfbp-5 mRNA, or brain Igf mRNA. CONCLUSIONS No benefits on body and brain weight gain but an effective increase in hepatic IGFBP-3 was observed after treatment with 2 mg/kg rhIGF-I during the early postnatal period.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
[The effect of insulin-like growth factor I and insulin on intrauterine fetal growth retardation].
April 1999, Zhonghua fu chan ke za zhi,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Postnatal effects of intrauterine treatment of the growth-restricted ovine fetus with intra-amniotic insulin-like growth factor-1.
December 2018, The Journal of physiology,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Insulin-like growth factor I--an important intrauterine growth factor.
October 1996, The New England journal of medicine,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene.
October 1996, The New England journal of medicine,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Nutritional modulation of insulin-like growth factor-I expression in early postnatal piglets.
July 1994, Pediatric research,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
High nutrient intake during the early postnatal period accelerates skeletal muscle fiber growth and maturity in intrauterine growth-restricted pigs.
January 2018, Genes & nutrition,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Specific decrease in liver insulin-like growth factor-I and brain insulin-like growth factor-II gene expression in energy-restricted rats.
August 1991, The Journal of nutrition,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
[Studies on insulin-like growth factor I receptor in fetal rats with intrauterine growth retardation].
September 2001, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats.
April 1995, The Journal of endocrinology,
Naho Ikeda, and Hiromichi Shoji, and Hiroki Suganuma, and Natsuki Ohkawa, and Masato Kantake, and Yayoi Murano, and Koji Sakuraya, and Toshiaki Shimizu
Translational status of the insulin-like growth factor-I mRNAs in liver of protein-restricted rats.
January 1992, The Journal of endocrinology,
Copied contents to your clipboard!